SCHEMBL995794

SCHEMBL995794

N#Cc1ccc(-c2ccc(C#N)cn2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 9/20 0.54
EGLN2 Q96KS0 1/20 0.53
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 4/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
HPGD P15428 2/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
KCNH2 Q12809 1/20 0.44
KDM1A O60341 1/20 0.43
CYP19A1 P11511 1/20 0.42
CYP1A2 P05177 1/20 0.41
CCR1 P32246 1/20 0.40
CCR5 P51681 1/20 0.40
CCR8 P51685 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
CYP2A6 P11509 1/20 0.40
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31172969 1.00 GRM5 (0.54) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL9021665 0.88 KDM4E (0.61) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL13986853 0.86 KDM4E (0.59) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL2937466 0.85 GRM5 (0.57) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL30492673 0.85 GRM5 (0.57) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL9022425 0.84 KDM4E (0.58) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL3775885 0.84 EGLN2 (0.46) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL18421817 0.84 GRM5 (0.44) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL29434446 0.84 HSD17B10 (0.45) GRM5EGLN2ALDH1A1KDM4EL3MBTL1
SCHEMBL14507290 0.83 EGLN2 (0.45) GRM5EGLN2ALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115634708-B Synthesis method and application of nitrogen-doped porous carbon-nickel supported catalyst 山东海科创新研究院有限公司 2023-11-21 CN claimed
US-20230167144-A1 PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) 2023-06-01 US claimed
CN-115634708-A Synthetic method and application of nitrogen-doped porous carbon nickel supported catalyst 山东海科创新研究院有限公司 2023-01-24 CN claimed
EP-2456555-A1 METHOD FOR OXIDIZING METHANE Studiengesellschaft Kohle MbH (DE) 2012-05-30 EP claimed
US-20120130071-A1 METHOD FOR OXIDIZING METHANE STUDIENGESELLSCHAFT KOHLE MBH (DE) 2012-05-24 US claimed
WO-2011009429-A1 METHOD FOR OXIDIZING METHANE STUDIENGESELLSCHAFT KOHLE MBH (DE) 2011-01-27 WO claimed
EP-4569559-A1 GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES Wisconsin Alumni Research Foundation (US) 2025-06-18 EP disclosed
CN-119856312-A Glass-like organic framework ion-conducting separator 威斯康星州男校友研究基金会 2025-04-18 CN disclosed
WO-2024036130-A1 GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2024-02-15 WO disclosed
CN-115634708-B Synthesis method and application of nitrogen-doped porous carbon-nickel supported catalyst 山东海科创新研究院有限公司 2023-11-21 CN disclosed
US-20230167144-A1 PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) 2023-06-01 US disclosed
CN-115634708-A Synthetic method and application of nitrogen-doped porous carbon nickel supported catalyst 山东海科创新研究院有限公司 2023-01-24 CN disclosed
CN-109206550-B Hybrid supermolecule dynamic polymer 厦门天策材料科技有限公司 2022-09-09 CN disclosed
US-20100280216-A1 METHOD OF PREPARING ORGANIC POROUS SOLIDS AND SOLIDS OBTAINABLE BY THIS METHOD MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) 2010-11-04 US disclosed
US-20100280216-A1 METHOD OF PREPARING ORGANIC POROUS SOLIDS AND SOLIDS OBTAINABLE BY THIS METHOD MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) 2010-11-04 US disclosed
EP-2014699-B1 Method of preparing organic porous solids and solids obtainable by this method MAX PLANCK GESELLSCHAFT (DE) 2009-09-02 EP disclosed
EP-2014699-A1 Method of preparing organic porous solids and solids obtainable by this method Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2009-01-14 EP disclosed
US-7393971-B2 Method for producing 3,3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-07-01 US disclosed
US-20070078278-A1 Method for producing 3, 3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2007-04-05 US disclosed
EP-1681282-A1 METHOD FOR PRODUCING 3,3-DIMETHYL-2-(1-PROPENYL) CYCLOPROPANE CARBOXYLATE Sumitomo Chemical Company, Limited (JP) 2006-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078278-A1 Method for producing 3, 3-dimethyl-2-(1-propenyl) cyclopropanecarboxylate AOC3, PDXK, AIPL1 GRM5 3862/4885EGLN2 654/4885ALDH1A1 92/4885
US-20120130071-A1 METHOD FOR OXIDIZING METHANE TST, MGMT, PMS2 GRM5 915/4885EGLN2 639/4885ALDH1A1 4463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.